143 related articles for article (PubMed ID: 38264246)
1. Environmental pressures, tumor characteristics, and death rate in a female breast cancer cohort: a seven-years Bayesian survival analysis using cancer registry data from a contaminated area in Italy.
Giannico OV; Carone S; Tanzarella M; Galluzzo C; Bruni A; Lagravinese GM; Rashid I; Bisceglia L; Sardone R; Addabbo F; Minerba S; Mincuzzi A
Front Public Health; 2023; 11():1310823. PubMed ID: 38264246
[TBL] [Abstract][Full Text] [Related]
2. Gender differences, environmental pressures, tumor characteristics, and death rate in a lung cancer cohort: a seven-years Bayesian survival analysis using cancer registry data from a contaminated area in Italy.
Mincuzzi A; Carone S; Galluzzo C; Tanzarella M; Lagravinese GM; Bruni A; Rashid I; Bisceglia L; Sardone R; Addabbo F; Minerba S; Giannico OV
Front Public Health; 2023; 11():1278416. PubMed ID: 38269375
[TBL] [Abstract][Full Text] [Related]
3. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy, safety, and acceptability of single-agent poly (ADP-ribose) polymerase (PARP) inhibitors in
Wang J; Zhang Y; Yuan L; Ren L; Zhang Y; Qi X
Aging (Albany NY); 2020 Nov; 13(1):450-459. PubMed ID: 33257598
[TBL] [Abstract][Full Text] [Related]
5. Bayesian synthesis using prior information on fracture risk from randomized trials to analyze post-market data.
John-Baptiste A; Becker T; Fung K; Lipscombe LL; Austin PC; Anderson GM
J Clin Epidemiol; 2018 Sep; 101():79-86. PubMed ID: 29879465
[TBL] [Abstract][Full Text] [Related]
6. EFFECT OF SELECTED PROGNOSTIC AND RISK FACTORS ON SURVIVAL OF WOMEN WITH BREAST CANCER IN GEORGIA.
Vashakidze N; Mebonia N; Kereselidze M; Gvamichava R; Zhizhilashvili S
Georgian Med News; 2018 Jun; (279):23-28. PubMed ID: 30035717
[TBL] [Abstract][Full Text] [Related]
7. [Report on health status of residents in areas with industrial, mining or military sites in Sardinia, Italy].
Biggeri A; Lagazio C; Catelan D; Pirastu R; Casson F; Terracini B
Epidemiol Prev; 2006; 30(1 Suppl 1):5-95. PubMed ID: 16826748
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
9. [SENTIERI Project: discussion and conclusions].
Pirastu R; Ricci P; Comba P; Bianchi F; Biggeri A; Conti S; Fazzo L; Forastiere F; Iavarone I; Martuzzi M; Musmeci L; Pasetto R; Zona A; Crocetti E
Epidemiol Prev; 2014; 38(2 Suppl 1):125-33. PubMed ID: 24986501
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database.
Robinson TJ; Wilson LE; Marcom PK; Troester M; Lynch CF; Hernandez BY; Parrilla E; Brauer HA; Dinan MA
JAMA Netw Open; 2021 Oct; 4(10):e2131020. PubMed ID: 34714340
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological features and prognosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer].
Wang Y; Zhang S; Zhang H; Liang L; Xu L; Cheng YJ; Duan XN; Liu YH; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):853-862. PubMed ID: 36241228
[TBL] [Abstract][Full Text] [Related]
12. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Anti-HER2 Targeted Therapy for Metastatic HR-Positive and HER2-Positive Breast Cancer: A Bayesian Network Meta-Analysis.
Wu XM; Qian YK; Chen HL; Hu CH; Chen BW
Curr Oncol; 2023 Sep; 30(9):8444-8463. PubMed ID: 37754530
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
[TBL] [Abstract][Full Text] [Related]
15. HR+/Her2- breast cancer in pre-menopausal women: The impact of younger age on clinical characteristics at diagnosis, disease management and survival.
De Camargo Cancela M; Comber H; Sharp L
Cancer Epidemiol; 2016 Dec; 45():162-168. PubMed ID: 27846443
[TBL] [Abstract][Full Text] [Related]
16. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
17. [Environment and health in Taranto, southern Italy: epidemiological studies and public health recommendations].
Comba P; Pirastu R; Conti S; De Santis M; Iavarone I; Marsili G; Mincuzzi A; Minelli G; Manno V; Minerba S; Musmeci L; Rashid I; Soggiu E; Zona A
Epidemiol Prev; 2012; 36(6):305-20. PubMed ID: 23293255
[TBL] [Abstract][Full Text] [Related]
18. [SENTIERI: Epidemiological Study of Residents in National Priority Contaminated Sites. Fifth Report].
Zona A; Iavarone I; Buzzoni C; Conti S; Santoro M; Fazzo L; Pasetto R; Pirastu R; Bruno C; Ancona C; Bianchi F; Forastiere F; Manno V; Minelli G; Minerba A; Minichilli F; Stoppa G; Pierini A; Ricci P; Scondotto S; Bisceglia L; Cernigliaro A; Ranzi A; Comba P; ; ;
Epidemiol Prev; 2019; 43(2-3 Suppl 1):1-208. PubMed ID: 31295974
[TBL] [Abstract][Full Text] [Related]
19. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
[TBL] [Abstract][Full Text] [Related]
20. Misclassification Adjustment of Family History of Breast Cancer in a Case-Control Study: a Bayesian Approach.
Moradzadeh R; Mansournia MA; Baghfalaki T; Ghiasvand R; Noori-Daloii MR; Holakouie-Naieni K
Asian Pac J Cancer Prev; 2015; 16(18):8221-6. PubMed ID: 26745064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
